Impact of a Lower Extremity Amputation Pathway Protocol in Dysvascular Patients

Age Range:18 - Any
Start Date:November 14, 2018
End Date:March 31, 2020
Contact:Rachel Dirks, PhD

Use our guide to learn which trials are right for you!

The LEAP protocol is a prospective cohort study of dysvascular patients designed to determine
whether implementation of a multi-disciplinary lower extremity amputation protocol in the
peri-operative period can shorten post-operative length of stay in patients undergoing
trans-tibial or trans-femoral amputations. A consecutive sample of patients diagnosed with
peripheral vascular disease and/or diabetes requiring major lower extremity amputation will
be enrolled in the study and compared to retrospective controls.

Inclusion Criteria:

- Patients >18 years of age diagnosed with peripheral vascular disease and/or diabetes

- Patients undergoing trans-tibial or trans-femoral amputations

Exclusion Criteria:

- Patients undergoing amputation for trauma, malignancy, or necrotizing fasciitis with
no dysvascular diagnosis

- Patients who have previously undergone an amputation

- Patients who were unable to function independently prior to admission

- Patients admitted to the ICU prior to surgery

- Attending surgeon does not approve of the patient being enrolled

- Prisoners

- Pregnant women
We found this trial at
Fresno, California 93721
Fresno, CA
Click here to add this to my saved trials